Logo image of CSIQ

CANADIAN SOLAR INC (CSIQ) Stock Fundamental Analysis

NASDAQ:CSIQ - Nasdaq - CA1366351098 - Common Stock - Currency: USD

9.8  -0.02 (-0.2%)

After market: 9.83 +0.03 (+0.31%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CSIQ. CSIQ was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. CSIQ may be in some trouble as it scores bad on both profitability and health. CSIQ is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CSIQ has reported negative net income.
In the past year CSIQ has reported a negative cash flow from operations.
CSIQ had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CSIQ reported negative operating cash flow in multiple years.
CSIQ Yearly Net Income VS EBIT VS OCF VS FCFCSIQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

With a Return On Assets value of -0.07%, CSIQ perfoms like the industry average, outperforming 43.64% of the companies in the same industry.
Looking at the Return On Equity, with a value of -0.37%, CSIQ is in line with its industry, outperforming 42.73% of the companies in the same industry.
Industry RankSector Rank
ROA -0.07%
ROE -0.37%
ROIC N/A
ROA(3y)1.74%
ROA(5y)1.75%
ROE(3y)8.12%
ROE(5y)7.8%
ROIC(3y)N/A
ROIC(5y)N/A
CSIQ Yearly ROA, ROE, ROICCSIQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of CSIQ has declined.
CSIQ has a worse Gross Margin (15.14%) than 83.64% of its industry peers.
CSIQ's Gross Margin has declined in the last couple of years.
CSIQ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-30.67%
PM growth 5Y-35.43%
GM growth 3Y-1.09%
GM growth 5Y-5.77%
CSIQ Yearly Profit, Operating, Gross MarginsCSIQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

0

2. Health

2.1 Basic Checks

CSIQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
CSIQ has more shares outstanding than it did 1 year ago.
CSIQ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CSIQ has a worse debt to assets ratio.
CSIQ Yearly Shares OutstandingCSIQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CSIQ Yearly Total Debt VS Total AssetsCSIQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

CSIQ has an Altman-Z score of 0.62. This is a bad value and indicates that CSIQ is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.62, CSIQ is doing worse than 72.73% of the companies in the same industry.
A Debt/Equity ratio of 1.37 is on the high side and indicates that CSIQ has dependencies on debt financing.
CSIQ has a Debt to Equity ratio of 1.37. This is amonst the worse of the industry: CSIQ underperforms 90.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 0.62
ROIC/WACCN/A
WACC3.59%
CSIQ Yearly LT Debt VS Equity VS FCFCSIQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B 3B

2.3 Liquidity

CSIQ has a Current Ratio of 1.07. This is a normal value and indicates that CSIQ is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.07, CSIQ is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
CSIQ has a Quick Ratio of 1.07. This is a bad value and indicates that CSIQ is not financially healthy enough and could expect problems in meeting its short term obligations.
CSIQ's Quick ratio of 0.80 is on the low side compared to the rest of the industry. CSIQ is outperformed by 91.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.8
CSIQ Yearly Current Assets VS Current LiabilitesCSIQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The earnings per share for CSIQ have decreased strongly by -193.75% in the last year.
Measured over the past years, CSIQ shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -28.29% on average per year.
Looking at the last year, CSIQ shows a very negative growth in Revenue. The Revenue has decreased by -19.06% in the last year.
Measured over the past years, CSIQ shows a quite strong growth in Revenue. The Revenue has been growing by 13.37% on average per year.
EPS 1Y (TTM)-193.75%
EPS 3Y-26.92%
EPS 5Y-28.29%
EPS Q2Q%-663.16%
Revenue 1Y (TTM)-19.06%
Revenue growth 3Y4.33%
Revenue growth 5Y13.37%
Sales Q2Q%-9.97%

3.2 Future

CSIQ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.21% yearly.
CSIQ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.75% yearly.
EPS Next Y82.1%
EPS Next 2Y75.23%
EPS Next 3Y60.53%
EPS Next 5Y52.21%
Revenue Next Year19.19%
Revenue Next 2Y18.18%
Revenue Next 3Y14.91%
Revenue Next 5Y11.75%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CSIQ Yearly Revenue VS EstimatesCSIQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
CSIQ Yearly EPS VS EstimatesCSIQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSIQ. In the last year negative earnings were reported.
CSIQ is valuated cheaply with a Price/Forward Earnings ratio of 6.36.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CSIQ indicates a rather cheap valuation: CSIQ is cheaper than 100.00% of the companies listed in the same industry.
CSIQ's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.77.
Industry RankSector Rank
PE N/A
Fwd PE 6.36
CSIQ Price Earnings VS Forward Price EarningsCSIQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSIQ is valued a bit cheaper than 75.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.65
CSIQ Per share dataCSIQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

CSIQ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSIQ's earnings are expected to grow with 60.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.23%
EPS Next 3Y60.53%

0

5. Dividend

5.1 Amount

No dividends for CSIQ!.
Industry RankSector Rank
Dividend Yield N/A

CANADIAN SOLAR INC

NASDAQ:CSIQ (5/23/2025, 9:24:42 PM)

After market: 9.83 +0.03 (+0.31%)

9.8

-0.02 (-0.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)08-20 2025-08-20
Inst Owners52.51%
Inst Owner Change-1.98%
Ins Owners21.2%
Ins Owner ChangeN/A
Market Cap656.21M
Analysts71.76
Price Target14.77 (50.71%)
Short Float %21.02%
Short Ratio4.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-692.5%
Min EPS beat(2)-1389.64%
Max EPS beat(2)4.63%
EPS beat(4)1
Avg EPS beat(4)-367.83%
Min EPS beat(4)-1389.64%
Max EPS beat(4)4.63%
EPS beat(8)3
Avg EPS beat(8)-34.38%
EPS beat(12)7
Avg EPS beat(12)6.9%
EPS beat(16)10
Avg EPS beat(16)32.65%
Revenue beat(2)1
Avg Revenue beat(2)0.97%
Min Revenue beat(2)-5.1%
Max Revenue beat(2)7.03%
Revenue beat(4)2
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-13.65%
Max Revenue beat(4)7.03%
Revenue beat(8)3
Avg Revenue beat(8)-3.47%
Revenue beat(12)5
Avg Revenue beat(12)-3.06%
Revenue beat(16)5
Avg Revenue beat(16)-3.78%
PT rev (1m)-7.82%
PT rev (3m)-10.41%
EPS NQ rev (1m)479.08%
EPS NQ rev (3m)278.51%
EPS NY rev (1m)-225.31%
EPS NY rev (3m)-51.3%
Revenue NQ rev (1m)8.51%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)0.59%
Revenue NY rev (3m)-0.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.36
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.24
P/tB 0.24
EV/EBITDA 12.65
EPS(TTM)-2.7
EYN/A
EPS(NY)1.54
Fwd EY15.73%
FCF(TTM)-39.93
FCFYN/A
OCF(TTM)-12.81
OCFYN/A
SpS87.53
BVpS41.36
TBVpS40.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.14%
FCFM N/A
ROA(3y)1.74%
ROA(5y)1.75%
ROE(3y)8.12%
ROE(5y)7.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-30.67%
PM growth 5Y-35.43%
GM growth 3Y-1.09%
GM growth 5Y-5.77%
F-Score1
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Debt/EBITDA 10.33
Cap/Depr 362.09%
Cap/Sales 30.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 0.8
Altman-Z 0.62
F-Score1
WACC3.59%
ROIC/WACCN/A
Cap/Depr(3y)379.19%
Cap/Depr(5y)289.93%
Cap/Sales(3y)19.88%
Cap/Sales(5y)15.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-193.75%
EPS 3Y-26.92%
EPS 5Y-28.29%
EPS Q2Q%-663.16%
EPS Next Y82.1%
EPS Next 2Y75.23%
EPS Next 3Y60.53%
EPS Next 5Y52.21%
Revenue 1Y (TTM)-19.06%
Revenue growth 3Y4.33%
Revenue growth 5Y13.37%
Sales Q2Q%-9.97%
Revenue Next Year19.19%
Revenue Next 2Y18.18%
Revenue Next 3Y14.91%
Revenue Next 5Y11.75%
EBIT growth 1Y-137.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year436.59%
EBIT Next 3Y96.51%
EBIT Next 5Y70.66%
FCF growth 1Y-227.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-229.32%
OCF growth 3YN/A
OCF growth 5YN/A